The CDMG has continued to meet monthly and discuss research prospects and pathways. The goals of the CDMG as originally envisioned include:

  1. Create a USA-based aggregate patient registry.
  2. Deploy omics technologies to help understand disease mechanisms and reveal biomarkers.
  3. Create model systems to assess biomarker conservation and perform high-throughput drug screens
  4. Obtain grant funding for research projects.
  5. Hold a symposium with patients and investigators to help train and build the research community.

We will report more specifics on these endeavors in our year-end newsletter.